Search

Author/Creator Helbig, Elisa T.

1. Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial. (March 2023)

Authors:
Kurth, Florian; Helbig, Elisa T.; Lippert, Lena J.; Thibeault, Charlotte; Barbone, Gianluca; Eckart, Marius A.; Kluge, Martin; Puengel, Tobias; Demir, Münevver; Röhle, Robert; Keller, Theresa; Ruwwe-Glösenkamp, Christoph; Witzenrath, Martin; Suttorp, Norbert; von Kalle, Christof; Sander, Leif E.;...
Journal:
Journal of global antimicrobial resistance
Issue:
Volume 32(2023)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. (October 2021)

Authors:
Mühlemann, Barbara; Thibeault, Charlotte; Hillus, David; Helbig, Elisa T.; Lippert, Lena J.; Tober-Lau, Pinkus; Schwarz, Tatjana; Müller, Marcel A.; Witzenrath, Martin; Suttorp, Norbert; Sander, Leif E.; Drosten, Christian; Jones, Terry C.; Corman, Victor M.; Kurth, Florian; Hippenstiel, Stefan; ...
Journal:
Clinical microbiology and infection
Issue:
Volume 27:Number 10(2021)
Page Start:
1520.e7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗